$IBIO news yesterday Fear In The Time Of Ebola
Post# of 22757
Fear In The Time Of Ebola Stocks: Debunking The iBio Bear Thesis
As a retail investor and physician, I was excited to come upon a stock, iBio Inc. (NYSE: IBIO), that I thought had the potential to revolutionize the production of vaccines and other medications through plant-based mass production. I was shocked and thrilled when on the day after I first bought the stock, the price per share went from $1.89 close on 10/16/14, to a $3.21 close on Friday 10/17/14, up about 70% in one day. After apparent profit-taking led to a closing price of 2.18 on 10/20/14. The following day an article by Adam Feuerstein of TheStreet made the case that iBio was overvalued at a market cap of almost $200 million.
The iBio stock price fell steadily to close at $1.77 on 10/22/14. On the following day an article by Melissa Davis of the StreetSweeper appeared, making the case that iBio was unlikely to be involved in ZMAPP production and had mislead investors with false claims. It was disclosed that StreetSweeper holds a short position in…
Read more »
Source: SeekingAlpha (November 4, 2014 - 4:09 PM EST)
News by QuoteMedia
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'